Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement | MicrobiomeTrials← Back to trialsNCT07526870
Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement
CompletedNAINTERVENTIONAL
Trial Details
Start: 2024-07-24Est. Completion: 2024-11-24
Enrollment target: 30 participants Locations- ✔ Instituto de Oftalmología Fundación Conde de Valenciana IAP, Mexico City, Mexico
Other microbiome trials you might be interested in
Emergency Department PatientComfort
Introduction: The aging of the population is a global phenomenon, with projections indicating a significant increase in …
São Paulo, BrazilEst. completion Mar 10, 2027
Health Behavior
Evaluate and compare the effects on female facial skin of oral placebo (Product A), N-acetylneuraminic acid (Product B),…
Wuhan, ChinaCompleted Dec 22, 2023
Skin Aging
SUISSELLE has developed a CE marketed (2021) HA-based superficial epidermis/dermis injection filler and skinbooster prod…
Villeurbanne, FranceEst. completion Aug 25, 2026